Zobrazeno 1 - 10
of 310
pro vyhledávání: '"S. Roden"'
Autor:
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, Vikrant Palande, Michelle A Rudek, Richard B S Roden
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0305710 (2024)
There is an urgent unmet need for more targeted and effective treatments for advanced epithelial ovarian cancer (EOC). The emergence of drug resistance is a particular challenge, but small molecule covalent inhibitors have promise for difficult targe
Externí odkaz:
https://doaj.org/article/2db63bf16e0e4c7bacaecfd447382c57
Autor:
Zhenwei Han, Shen Wang, Ting Mu, Ping Zhao, Lingli Song, Ying Zhang, Jin Zhao, Wen Yin, Yue Wu, Huan Wang, Bo Gong, Min Ji, Richard B. S. Roden, Yanping Yang, Michel Klein, Ke Wu
Publikováno v:
Vaccines, Vol 12, Iss 6, p 689 (2024)
Human papillomavirus (HPV) is a prevalent cause of mucosal and cutaneous infections and underlying conditions ranging from benign warts to anogenital and oropharyngeal cancers affecting both males and females, notably cervical cancer. Cervical cancer
Externí odkaz:
https://doaj.org/article/e93fdf05148e493eae57b2a5ab01787f
Autor:
Shiwen Peng, Hsin-Fang Tu, Michelle Cheng, Ming-Hung Hu, Hua-Ling Tsai, Ya-Chea Tsai, Chelsea Koenig, Cory Brayton, Hao Wang, Yung-Nien Chang, Rebecca C. Arend, Kimberly Levinson, Richard B. S. Roden, T. C. Wu, Chien-Fu Hung
Publikováno v:
mBio, Vol 14, Iss 5 (2023)
ABSTRACT Intramuscular vaccination of mice with the naked pBI-11 DNA plasmid targeting E6 and E7 of HPV16 and HPV18 via a conventional syringe and needle generates human papillomavirus (HPV) antigen-specific CD8+ T cell-mediated immune responses and
Externí odkaz:
https://doaj.org/article/00f8f784520d4cb3a7d4be511b1e4720
Autor:
Franziska Kuehner, Margaret Wong, Elke Straub, John Doorbar, Thomas Iftner, Richard B. S. Roden, Frank Stubenrauch
Publikováno v:
mBio, Vol 14, Iss 4 (2023)
ABSTRACT High-risk human papillomaviruses (PV) account for approximately 600,000 new cancers per year. The early protein E8^E2 is a conserved repressor of PV replication, whereas E4 is a late protein that arrests cells in G2 and collapses keratin fil
Externí odkaz:
https://doaj.org/article/83cafb49b78c44eea0451914b3ed452e
Autor:
Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, Ssu-Hsueh Tseng, Samarjit Das, Fernanda Carrizo Velasquez, Balasubramanyam Karanam, Deepika Poddatoori, Ramesh Patnam, Michelle A Rudek, Yung-Nien Chang, Richard B S Roden
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0285221 (2023)
Bortezomib has been successful for treatment of multiple myeloma, but not against solid tumors, and toxicities of neuropathy, thrombocytopenia and the emergence of resistance have triggered efforts to find alternative proteasome inhibitors. Bis-benzy
Externí odkaz:
https://doaj.org/article/9b4e3a1ede114e78983838d19f4e8731
Autor:
Ruey-Shyang Soong, Ravi K. Anchoori, Richard B. S. Roden, Rou-Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng, Yun-Li Huang, Po-Cheng Liao, Yu-Chiau Shyu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background According to GLOBOSCAN, hepatocellular carcinoma (HCC) claimed 782,000 lives in 2018. The tyrosine kinase inhibitor sofafenib is used to treat HCC, but new anticancer agents targeting different pathways are urgently needed to impr
Externí odkaz:
https://doaj.org/article/44a667359ad24cdaa8fc5e8ea4089343
Autor:
Ravi K. Anchoori, Rosie Jiang, Shiwen Peng, Ruey-shyang Soong, Aliyah Algethami, Michelle A. Rudek, Nicole Anders, Chien-Fu Hung, Xiang Chen, Xiuxiu Lu, Olumide Kayode, Marzena Dyba, Kylie J. Walters, Richard B. S. Roden
Publikováno v:
ACS Omega, Vol 3, Iss 9, Pp 11917-11929 (2018)
Externí odkaz:
https://doaj.org/article/ddb3d390b0824e9bb143313880ac9c72
Autor:
Frederick S. Roden
Publikováno v:
Religion and the Arts. 26:694-698
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa7cdf54aac69a58613f5006239cdba3
https://doi.org/10.1163/15685292-02605009
https://doi.org/10.1163/15685292-02605009
Autor:
Rosie T. Jiang, Anna Yemelyanova, Deyin Xing, Ravi K. Anchoori, Jun Hamazaki, Shigeo Murata, Jeffrey D. Seidman, Tian-Li Wang, Richard B. S. Roden
Publikováno v:
Journal of Ovarian Research, Vol 10, Iss 1, Pp 1-12 (2017)
Abstract Background Ovarian carcinoma is highly dependent on the ubiquitin proteasome system (UPS), but its clinical response to treatment with the proteasome inhibitor bortezomib has been disappointing. This has driven exploration of alternate appro
Externí odkaz:
https://doaj.org/article/9ff98f8274cc4f019b69a84610a69d51
Autor:
Frederick S. Roden
Publikováno v:
Religion and the Arts. 26:401-405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a26f47936c38e03d24d4e27c5c08caa0
https://doi.org/10.1163/15685292-02603011
https://doi.org/10.1163/15685292-02603011